We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+54.45%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$4.6B
AUM Growth
+$1.51B
Cap. Flow
+$217M
Cap. Flow %
4.71%
Top 10 Hldgs %
30.3%
Holding
146
New
24
Increased
37
Reduced
22
Closed
12

Top Buys

Rank Stock Value
1
PLRX icon
Pliant Therapeutics
PLRX
+$75.3M
2
TT icon
Trane Technologies
TT
+$39.3M
3
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$35.1M
4
EXAS
Exact Sciences
EXAS
+$27.8M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$22.1M

Top Sells

Rank Stock Value
1
XYL icon
Xylem
XYL
+$51.6M
2
TWLO icon
Twilio
TWLO
+$48M
3
ZGNX
Zogenix, Inc.
ZGNX
+$45M
4
VRNS icon
Varonis Systems
VRNS
+$26.7M
5
SAGE
Sage Therapeutics
SAGE
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 45.14%
2 Technology 22.43%
3 Industrials 8.89%
4 Consumer Discretionary 7.31%
5 Communication Services 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$253M 5.5%
1,709,848
+11,200
+0.7% +$1.54M
SRPT icon
2
Sarepta Therapeutics
SRPT
$1.64B
$160M 3.47%
996,000
– –
EXAS
3
DELISTED
Exact Sciences
EXAS
$151M 3.29%
1,740,000
+348,000
+25% +$27.8M
IGV icon
4
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$12.5B
$138M 2.99%
3,000,000
+1,545,000
+106% +$77.5M
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$130M 2.83%
1,783,761
– –
FIVN icon
6
FIVE9
FIVN
$2.12B
$127M 2.77%
1,151,000
-67,000
-6% -$6.52M
TTD icon
7
Trade Desk
TTD
$8.59B
$122M 2.65%
3,000,000
– –
W icon
8
Wayfair
W
$11.9B
$113M 2.46%
573,000
– –
KRTX
9
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$100M 2.18%
901,077
– –
CRWD icon
10
CrowdStrike
CRWD
$189B
$99M 2.15%
3,948,000
– –
ROP icon
11
Roper Technologies
ROP
$38.5B
$90.2M 1.96%
232,400
+18,400
+9% +$6.59M
PLRX icon
12
Pliant Therapeutics
PLRX
$65.6M
$88.4M 1.92%
+2,838,125
New +$75.3M
TWLO icon
13
Twilio
TWLO
$29B
$84.7M 1.84%
386,000
-299,000
-44% -$48M
LOW icon
14
Lowe's Companies
LOW
$118B
$81.1M 1.76%
599,900
+3,300
+0.6% +$377K
SPLK
15
DELISTED
Splunk Inc
SPLK
$75.5M 1.64%
380,000
-48,000
-11% -$7.59M
WCN
16
Waste Connections
WCN
$41.9B
$75.4M 1.64%
804,000
– –
DT icon
17
Dynatrace
DT
$12.8B
$75.1M 1.63%
1,849,500
-226,900
-11% -$7.47M
MTD icon
18
Mettler-Toledo International
MTD
$27.9B
$73.3M 1.59%
91,000
+20,000
+28% +$14.9M
POOL icon
19
Pool Corp
POOL
$6.95B
$67.8M 1.47%
249,200
+63,200
+34% +$14.6M
LRCX icon
20
Lam Research
LRCX
$372B
$65M 1.41%
2,010,000
– –
XIFR
21
XPLR Infrastructure LP
XIFR
$1.12B
$64.5M 1.4%
1,258,100
+15,300
+1% +$741K
ASML icon
22
ASML
ASML
$634B
$63.3M 1.38%
172,000
– –
MYOK
23
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$60M 1.3%
621,000
– –
ARGX icon
24
argenx
ARGX
$54.6B
$59.5M 1.29%
264,000
-33,300
-11% -$5.91M
LII icon
25
Lennox International
LII
$14.5B
$59.4M 1.29%
255,000
– –
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Eventide Asset Management held 146 positions worth $4.6B, up 49% from $3.09B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Eventide Asset Management deployed $217M of net new capital in Q2 2020, opening 24 new positions and adding to 37 existing holdings. Its largest new stake was Pliant Therapeutics: 2,838,125 shares worth $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 44% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Twilio, an estimated $48M trimmed.

  • Eventide Asset Management's largest Q2 2020 buy was Pliant Therapeutics: 2,838,125 shares worth $88.4M.
  • Eventide Asset Management added most to Trane Technologies in Q2 2020, an estimated $39.3M increase.
  • Eventide Asset Management's biggest Q2 2020 reduction was Twilio, cutting an estimated $48M.
  • Eventide Asset Management fully exited Xylem in Q2 2020, selling an estimated $51.6M.
  • Eventide Asset Management's ten largest holdings make up 30% of its $4.6B portfolio in Q2 2020.
  • Eventide Asset Management opened 24 new positions and closed 12 in Q2 2020.
  • Eventide Asset Management's portfolio value rose 49% quarter-over-quarter to $4.6B.

Based on Eventide Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.